|
1
|
Kalampokas E, Giannis G, Kalampokas T,
Papathanasiou AA, Mitsopoulou D, Tsironi E, Triantafyllidou O,
Gurumurthy M, Parkin DE, Cairns M and Vlahos NF: Current approaches
to the management of patients with endometrial cancer. Cancers
(Basel). 14:45002022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hamilton CA, Pothuri B, Arend RC, Backes
FJ, Gehrig PA, Soliman PT, Thompson JS, Urban RR and Burke WM:
Endometrial cancer: A society of gynecologic oncology
evidence-based review and recommendations. Gynecol Oncol.
160:817–826. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crosbie EJ, Kitson SJ, McAlpine JN,
Mukhopadhyay A, Powell ME and Singh N: Endometrial cancer. Lancet.
399:1412–1428. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Madariaga A, Coleman RL and González
Martín A: Novel therapies leading to a new landscape in gynecologic
tumors. Int J Gynecol Cancer. 33:321–322. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Inoue F, Sone K, Toyohara Y, Tanimoto S,
Takahashi Y, Kusakabe M, Kukita A, Honjoh H, Nishijima A, Taguchi
A, et al: Histone arginine methyltransferase CARM1 selective
inhibitor TP-064 induces apoptosis in endometrial cancer. Biochem
Biophys Res Commun. 601:123–128. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pirš B, Škof E, Smrkolj V and Smrkolj Š:
Overview of immune checkpoint inhibitors in gynecological cancer
treatment. Cancers (Basel). 14:6312022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park JY, Lee JY, Lee YY, Shim SH, Suh DH
and Kim JW: Major clinical research advances in gynecologic cancer
in 2021. J Gynecol Oncol. 33:e432022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yanazume S, Iwakiri K, Kobayashi Y,
Kitazono I, Akahane T, Mizuno M, Togami S, Tanimoto A and Kobayashi
H: Cytopathological features associated with POLE mutation in
endometrial cancer. Cytopathology. Feb 2–2023.doi:
10.1111/cyt.13215 (Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mullen MM and Mutch DG: Endometrial tumor
immune response: Predictive biomarker of response to immunotherapy.
Clin Cancer Res. 25:2366–2368. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rousset-Rouviere S, Rochigneux P, Chrétien
AS, Fattori S, Gorvel L, Provansal M, Lambaudie E, Olive D and
Sabatier R: Endometrial carcinoma: Immune microenvironment and
emerging treatments in immuno-oncology. Biomedicines. 9:6322021.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Talhouk A, Derocher H, Schmidt P, Leung S,
Milne K, Gilks CB, Anglesio MS, Nelson BH and McAlpine JN:
Molecular subtype not immune response drives outcomes in
endometrial carcinoma. Clin Cancer Res. 25:2537–2548. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Burke KP, Patterson DG, Liang D and Sharpe
AH: Immune checkpoint receptors in autoimmunity. Curr Opin Immunol.
80:1022832023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Izawa M, Tanaka N, Murakami T, Anno T,
Teranishi Y, Takamatsu K, Mikami S, Kakimi K, Imamura T, Matsumoto
K and Oya M: Single-cell phenotyping of CD73 expression reveals the
diversity of the tumor immune microenvironment and reflects the
prognosis of bladder cancer. Lab Invest. 103:1000402023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ashouri JF, Lo WL, Nguyen TTT, Shen L and
Weiss A: TZAP70, too little, too much can lead to autoimmunity.
Immunol Rev. 307:145–160. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chakraborty AK and Weiss A: Insights into
the initiation of TCR signaling. Nat Immunol. 15:798–807. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leveille E, Chan LN, Mirza AS, Kume K and
Müschen M: SYK and ZAP70 kinases in autoimmunity and lymphoid
malignancies. Cell Signal. 94:1103312022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Linley AJ and Slupsky JR: Poor prognosis
is ZAP70′ed into focus in CLL. Blood. 137:3586–3587. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rosenwald A, Alizadeh AA, Widhopf G, Simon
R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, et
al: Relation of gene expression phenotype to immunoglobulin
mutation genotype in B cell chronic lymphocytic leukemia. J Exp
Med. 194:1639–1647. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Au-Yeung BB, Levin SE, Zhang C, Hsu LY,
Cheng DA, Killeen N, Shokat KM and Weiss A: A genetically selective
inhibitor demonstrates a function for the kinase Zap70 in
regulatory T cells independent of its catalytic activity. Nat
Immunol. 11:1085–1092. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Colaprico A, Silva TC, Olsen C, Garofano
L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM,
Castiglioni I, et al: TCGAbiolinks: An R/Bioconductor package for
integrative analysis of TCGA data. Nucleic Acids Res. 44:e712016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yan G, An Y, Xu B, Wang N, Sun X and Sun
M: Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon
Adenocarcinoma. Front Oncol. 11:6704902021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Langfelder P and Horvath S: Eigengene
networks for studying the relationships between co-expression
modules. BMC Syst Biol. 1:542007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reimand J, Isserlin R, Voisin V, Kucera M,
Tannus-Lopes C, Rostamianfar A, Wadi L, Meyer M, Wong J, Xu C, et
al: Pathway enrichment analysis and visualization of omics data
using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc.
14:482–517. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tibshirani R: The lasso method for
variable selection in the Cox model. Stat Med. 16:385–395. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wilkerson MD and Hayes DN:
ConsensusClusterPlus: A class discovery tool with confidence
assessments and item tracking. Bioinformatics. 26:1572–1573. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yoshihara K, Shahmoradgoli M, Martínez E,
Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW,
Levine DA, et al: Inferring tumour purity and stromal and immune
cell admixture from expression data. Nat Commun. 4:26122013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Newman AM, Liu CL, Green MR, Gentles AJ,
Feng W, Xu Y, Hoang CD, Diehn M and Alizadeh AA: Robust enumeration
of cell subsets from tissue expression profiles. Nat Methods.
12:453–457. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hänzelmann S, Castelo R and Guinney J:
GSVA: Gene set variation analysis for microarray and RNA-seq data.
BMC Bioinformatics. 14:72013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Greenwood JD, Minhas K, di Santo JP,
Makita M, Kiso Y and Croy BA: Ultrastructural studies of
implantation sites from mice deficient in uterine natural killer
cells. Placenta. 21:693–702. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kolben T, Mannewitz M, Perleberg C,
Schnell K, Anz D, Hahn L, Meister S, Schmoeckel E, Burges A,
Czogalla B, et al: Presence of regulatory T-cells in endometrial
cancer predicts poorer overall survival and promotes progression of
tumor cells. Cell Oncol (Dordr). 45:1171–1185. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Degos C, Heinemann M, Barrou J, Boucherit
N, Lambaudie E, Savina A, Gorvel L and Olive D: Endometrial tumor
microenvironment alters human NK cell recruitment, and resident NK
cell phenotype and function. Front Immunol. 10:8772019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang XQ, Zhou WJ, Luo XZ, Tao Y and Li DJ:
Synergistic effect of regulatory T cells and proinflammatory
cytokines in angiogenesis in the endometriotic milieu. Hum Reprod.
32:1304–1317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yu Z, Zhang J, Zhang Q, Wei S, Shi R, Zhao
R, An L, Grose R, Feng D and Wang H: Single-cell sequencing reveals
the heterogeneity and intratumoral crosstalk in human endometrial
cancer. Cell Prolif. 55:e132492022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Antsiferova YS, Sotnikova NY, Posiseeva LV
and Shor AL: Changes in the T-helper cytokine profile and in
lymphocyte activation at the systemic and local levels in women
with endometriosis. Fertil Steril. 84:1705–1711. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hofmann AP, Gerber SA and Croy BA: Uterine
natural killer cells pace early development of mouse decidua
basalis. Mol Hum Reprod. 20:66–76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Heikkinen J, Möttönen M, Alanen A and
Lassila O: Phenotypic characterization of regulatory T cells in the
human decidua. Clin Exp Immunol. 136:373–378. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fu B, Li X, Sun R, Tong X, Ling B, Tian Z
and Wei H: Natural killer cells promote immune tolerance by
regulating inflammatory TH17 cells at the human maternal-fetal
interface. Proc Natl Acad Sci USA. 110:E231–E240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Diao R, Wei W, Zhao J, Tian F, Cai X and
Duan YG: CCL19/CCR7 contributes to the pathogenesis of
endometriosis via PI3K/Akt pathway by regulating the proliferation
and invasion of ESCs. Am J Reprod Immunol. 782017.doi:
10.1111/aji.12744 (Epub ahead of print).
|
|
45
|
Mei J, Zhou WJ, Zhu XY, Lu H, Wu K, Yang
HL, Fu Q, Wei CY, Chang KK, Jin LP, et al: Suppression of autophagy
and HCK signaling promotes PTGS2high FCGR3-NK cell differentiation
triggered by ectopic endometrial stromal cells. Autophagy.
14:1376–1397. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Agostinis C, Masat E, Bossi F, Ricci G,
Menegazzi R, Lombardelli L, Zito G, Mangogna A, Degan M, Gattei V,
et al: Transcriptomics and immunological analyses reveal a
pro-angiogenic and anti-inflammatory phenotype for decidual
endothelial cells. Int J Mol Sci. 20:16042019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hollebecque A, Chung HC, de Miguel MJ,
Italiano A, Machiels JP, Lin CC, Dhani NC, Peeters M, Moreno V, Su
WC, et al: Safety and antitumor activity of α-PD-L1 antibody as
monotherapy or in combination with α-TIM-3 antibody in patients
with microsatellite instability-high/mismatch repair-deficient
tumors. Clin Cancer Res. 27:6393–6404. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Marabelle A, Le DT, Ascierto PA, Di
Giacomo AM, De Jesus-Acosta A, Delord JP, Geva R, Gottfried M,
Penel N, Hansen AR, et al: Efficacy of pembrolizumab in patients
with noncolorectal high microsatellite instability/mismatch
repair-deficient cancer: Results from the phase II KEYNOTE-158
study. J Clin Oncol. 38:1–10. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Antill Y, Kok PS, Robledo K, Yip S,
Cummins M, Smith D, Spurdle A, Barnes E, Lee YC, Friedlander M, et
al: Clinical activity of durvalumab for patients with advanced
mismatch repair-deficient and repair-proficient endometrial cancer.
A nonrandomized phase 2 clinical trial. J Immunother Cancer.
9:e0022552021. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen L, Widhopf G, Huynh L, Rassenti L,
Rai KR, Weiss A and Kipps TJ: Expression of ZAP-70 is associated
with increased B-cell receptor signaling in chronic lymphocytic
leukemia. Blood. 100:4609–4614. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen L, Apgar J, Huynh L, Dicker F,
Giago-McGahan T, Rassenti L, Weiss A and Kipps TJ: ZAP-70 directly
enhances IgM signaling in chronic lymphocytic leukemia. Blood.
105:2036–2041. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu Y, Wang Y, Yang J, Bi Y and Wang H:
ZAP-70 in chronic lymphocytic leukemia: A meta-analysis. Clin Chim
Acta. 483:82–88. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sun M, Chen S and Fu M: Model
establishment of prognostic-related immune genes in laryngeal
squamous cell carcinoma. Medicine (Baltimore). 100:e242632021.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu J and Zhang J: T-cell receptors
provide potential prognostic signatures for breast cancer. Cell
Biol Int. 45:1220–1230. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sun X, Wang L, Li H, Jin C, Yu Y, Hou L,
Liu X, Yu Y, Yan R and Xue F: Identification of microenvironment
related potential biomarkers of biochemical recurrence at 3 years
after prostatectomy in prostate adenocarcinoma. Aging (Albany NY).
13:16024–16042. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Brito C, Costa-Silva B, Barral DC and Pojo
M: Unraveling the relevance of ARL GTpases in cutaneous melanoma
prognosis through integrated bioinformatics analysis. Int J Mol
Sci. 22:92602021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kang Z, Li W, Yu YH, Che M, Yang ML, Len
JJ, Wu YR and Yang JF: Identification of Immune-related genes
associated with bladder cancer based on immunological
characteristics and their correlation with the prognosis. Front
Genet. 12:7635902021. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lyu M, Yi X, Huang Z, Chen Y, Ai Z, Liang
Y, Feng Q and Xiang Z: A transcriptomic analysis based on aberrant
methylation levels revealed potential novel therapeutic targets for
nasopharyngeal carcinoma. Ann Transl Med. 10:472022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jan CI, Huang SW, Canoll P, Bruce JN, Lin
YC, Pan CM, Lu HM, Chiu SC and Cho DY: Targeting human leukocyte
antigen G with chimeric antigen receptors of natural killer cells
convert immunosuppression to ablate solid tumors. J Immunother
Cancer. 9:e0030502021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yin X, He L and Guo Z: T-cell exhaustion
in CAR-T-cell therapy and strategies to overcome it. Immunology.
Mar 20–2023.doi: 10.1111/imm.13642 (Epub ahead of print).
View Article : Google Scholar
|
|
61
|
Rowan AG, Ponnusamy K, Ren H, Taylor GP,
Cook LBM and Karadimitris A: CAR-iNKT cells targeting clonal TCRVβ
chains as a precise strategy to treat T cell lymphoma. Front
Immunol. 14:11186812023. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Brentjens RJ, Latouche JB, Santos E, Marti
F, Gong MC, Lyddane C, King PD, Larson S, Weiss M, Rivière I and
Sadelain M: Eradication of systemic B-cell tumors by genetically
targeted human T lymphocytes co-stimulated by CD80 and
interleukin-15. Nat Med. 9:279–286. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Gladkikh AA, Potashnikova DM, Tatarskiy V
Jr, Yastrebova M, Khamidullina A, Barteneva N and Vorobjev I:
Comparison of the mRNA expression profile of B-cell receptor
components in normal CD5-high B-lymphocytes and chronic lymphocytic
leukemia: A key role of ZAP70. Cancer Med. 6:2984–2997. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Lin JX and Leonard WJ: The common cytokine
Receptor γ chain family of cytokines. Cold Spring Harb Perspect
Biol. 10:a0284492018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Blanco E, Izotova N, Booth C and Thrasher
AJ: Immune reconstitution after gene therapy approaches in patients
with X-Linked severe combined immunodeficiency disease. Front
Immunol. 11:6086532020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Le DT, Durham JN, Smith KN, Wang H,
Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, et
al: Mismatch repair deficiency predicts response of solid tumors to
PD-1 blockade. Science. 357:409–413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Oh MS and Chae YK: Deep and durable
response with combination CTLA-4 and PD-1 blockade in mismatch
repair (MMR)-proficient endometrial cancer. J Immunother. 42:51–54.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Faulkner S, Jobling P, March B, Jiang CC
and Hondermarck H: Tumor neurobiology and the war of nerves in
cancer. Cancer Discov. 9:702–710. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Chen F, Qin T, Zhang Y, Wei L, Dang Y, Liu
P and Jin W: Reclassification of endometrial cancer and
identification of key genes based on neural-related genes. Front
Oncol. 12:9514372022. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Blake MK, O'Connell P and Aldhamen YA:
Fundamentals to therapeutics: Epigenetic modulation of CD8+ T Cell
exhaustion in the tumor microenvironment. Front Cell Dev Biol.
10:10821952022. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Philip M and Schietinger A: CD8+ T cell
differentiation and dysfunction in cancer. Nat Rev Immunol.
22:209–223. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Duckworth BC, Qin RZ and Groom JR: Spatial
determinates of effector and memory CD8+ T cell fates. Immunol Rev.
306:76–92. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Nelson MA, Ngamcherdtrakul W, Luoh SW and
Yantasee W: Prognostic and therapeutic role of tumor-infiltrating
lymphocyte subtypes in breast cancer. Cancer Metastasis Rev.
40:519–536. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Mestermann K, Giavridis T, Weber J, Rydzek
J, Frenz S, Nerreter T, Mades A, Sadelain M, Einsele H and Hudecek
M: The tyrosine kinase inhibitor dasatinib acts as a pharmacologic
on/off switch for CAR T cells. Sci Transl Med. 11:eaau59072019.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Brunner A, Hinterholzer S, Riss P, Heinze
G and Brustmann H: Immunoexpression of B7-H3 in endometrial cancer:
Relation to tumor T-cell infiltration and prognosis. Gynecol Oncol.
124:105–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
